Value-based healthcare is predicated on collaboration. Sharing of data, methods, pathways and perspectives among different stakeholders is paramount if the transition to value-based care is to be fully realized. Instead of relying solely on legacy methods to measure value, IVI's Open-Source Value Platform (OSVP) uses a transparent and open-source process to develop methods and tools [...]
IVI's Director of Scientific Communications, Mark Linthicum, sits down with the Journal of Clinical Pathways for a webinar discussion about IVI's open-source model for assessing value in non-small cell lung cancer therapies. If you want to learn more about IVI's open-source approach to value assessment, this webinar is a great place to start. Click here to [...]
IVI will host two upcoming webinars focused on its new disease-specific, open-source value model to assess EGFR+ non-small cell lung cancer (NSCLC) therapy sequences. These webinars are free and open to the public. We hope you will join us to learn more about IVI's Open-Source Value Project (OSVP) and the new IVI-NSCLC model. Detailed information and [...]
In an article published on AJMC.com, IVI'sJennifer Bright discusses how IVI makes incorporating patients' perspectives a priority in developing open-source, transparent value models. Read the full article here.